Primary and secondary outcomes by trial arm
| LMA (intervention) n=24 mean (SD) range | Face mask (comparator) n=25 mean (SD) range | p Value | Effect of the intervention Mean ratio (95% CI) | |
| Primary outcome | 0.005 | 0.70 (0.56 to 0.89) | ||
| Time to spontaneous breathing (s) | 153 (59) 45–300 | 216 (92) 65–395 | ||
| n (%) | n (%) | OR (95% CI) | ||
| Secondary outcomes | ||||
| Admission to neonatal unit (first 48 hours) | 5 (21) | 8 (32) | 0.52 | 0.56 (0.12 to 2.42) |
| Neonatal encephalopathy | 0 | 2 (8) | 0.49 | 0.00 (0.00 to 5.51) |
| Death within 48 hours | 0 | 1 (4) | 0.99 | 0.00 (0.00 to 40.63) |
| Adverse effects (vomiting, bleeding or laryngospasm) | 0 | 0 | 0.99 | Not applicable |
LMA, laryngeal mask airway.